AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2012

Oct 26, 2012

30718_dirs_2012-10-26_47053df5-327e-45b5-b18c-f43c6b4de821.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2012-10-25

Reporting Person: OCONNELL HOWARD V (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-25	Stock Option	$66.9	A	5000	Acquired	2022-10-24	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	90639	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Option	$61.46	2020-10-27	Common Stock (5000)	5000	Direct
Stock Options	$63.03	2019-10-28	Common Stock (5000)	5000	Indirect
Stock Option	$65.47	2018-10-22	Common Stock (5000)	5000	Indirect
Stock Option	$66.59	2017-10-24	Common Stock (5000)	5000	Indirect
Stock Option	$56.17	2016-10-25	Common Stock (5000)	5000	Indirect
STock Option	$54.68	2015-10-26	Common Stock (5000)	5000	Indirect
Stock Option	$37.1	2014-10-20	Common Stock (5000)	5000	Indirect